Download PDF
CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2023; 07(01): 034-045
DOI: 10.1055/s-0042-1748818
Review Article

Expanding Indications of TIPS in the Management of Portal Hypertension Complications

Sai Swarupa Reddy Vulasala 
1   Department of Radiology, University of Florida College of Medicine, Jacksonville, Florida, United States
,
Nirmal Kumar Reddy Onteddu 
2   Division of Hospital Medicine, Department of Internal Medicine, Flowers Hospital, Dothan, Alabama, United States
,
Sanjeeva Prasad Kalva 
3   Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, United States
,
Sara Smolinski-Zhao 
3   Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, United States
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is a nonsurgical intervention to reduce portal pressure by creating a low-resistance channel between the portal and systemic circulations. It is a well-accepted treatment for gastroesophageal varices and refractory ascites. This review aims to discuss the evidence-based applications of TIPS in other complications of portal hypertension beyond gastroesophageal varices and refractory ascites.

Keywords

portal hypertension - TIPS - expanding indications of TIPS


Publication History

Article published online:
31 May 2022

© 2022. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Pinchot JW, Kalva SP, Majdalany BS. et al; Expert Panels on Interventional Radiology and Vascular Imaging. ACR Appropriateness Criteria® radiologic management of portal hypertension. J Am Coll Radiol 2021; 18 (5S): S153-S173
    CrossrefPubMedGoogle Scholar
  • 2 Augustin S, Millán L, González A. et al. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study. J Hepatol 2014; 60 (03) 561-569
    CrossrefPubMedGoogle Scholar
  • 3 Tripathi D, Stanley AJ, Hayes PC. et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 2020; 69 (07) 1173-1192
    CrossrefPubMedGoogle Scholar
  • 4 Smith M, Durham J. Evolving indications for tips. Tech Vasc Interv Radiol 2016; 19 (01) 36-41
    CrossrefPubMedGoogle Scholar
  • 5 Ditah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: a systematic review and cumulative meta-analysis. World J Hepatol 2015; 7 (13) 1797-1806
    CrossrefPubMedGoogle Scholar
  • 6 Rajesh S, George T, Philips CA. et al. Transjugular intrahepatic portosystemic shunt in cirrhosis: an exhaustive critical update. World J Gastroenterol 2020; 26 (37) 5561-5596
    CrossrefPubMedGoogle Scholar
  • 7 Garbuzenko DV, Arefyev NO. Hepatic hydrothorax: an update and review of the literature. World J Hepatol 2017; 9 (31) 1197-1204
    CrossrefPubMedGoogle Scholar
  • 8 Campos S, Gomes D, Sofia C. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication. Eur J Gastroenterol Hepatol 2016; 28 (06) 661-666
    CrossrefPubMedGoogle Scholar
  • 9 Chow E, Khiatah B, Frugoli A. Refractory spontaneous bacterial empyema in cirrhotic patient. Case Rep Gastrointest Med 2021. 2021 :6685998
    PubMedGoogle Scholar
  • 10 Jindal A, Mukund A, Kumar G, Sarin SK. Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosis. Liver Int 2019; 39 (11) 2164-2173
    CrossrefPubMedGoogle Scholar
  • 11 Garcia-Pagán JC, Heydtmann M, Raffa S. et al; Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008; 135 (03) 808-815
    CrossrefPubMedGoogle Scholar
  • 12 Martens P, Nevens F. Budd-Chiari syndrome. United European Gastroenterol J 2015; 3 (06) 489-500
    CrossrefPubMedGoogle Scholar
  • 13 Sonavane AD, Amarapurkar DN, Rathod KR, Punamiya SJ. Long term survival of patients undergoing TIPS in Budd-Chiari syndrome. J Clin Exp Hepatol 2019; 9 (01) 56-61
    CrossrefPubMedGoogle Scholar
  • 14 Ryu RK, Durham JD, Krysl J. et al. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J Vasc Interv Radiol 1999; 10 (06) 799-805
    CrossrefPubMedGoogle Scholar
  • 15 McCarthy PM, van Heerden JA, Adson MA, Schafer LW, Wiesner RH. The Budd-Chiari syndrome. Medical and surgical management of 30 patients. Arch Surg 1985; 120 (06) 657-662
    CrossrefPubMedGoogle Scholar
  • 16 Mancuso A. An update on the management of Budd-Chiari syndrome: the issues of timing and choice of treatment. Eur J Gastroenterol Hepatol 2015; 27 (03) 200-203
    CrossrefPubMedGoogle Scholar
  • 17 Lupasco I, Dumbrava V-T. Diagnosis and therapy of Budd Chiari syndrome. Med Pharm Rep 2021; 94 (Suppl No 1): S68-S71
    PubMedGoogle Scholar
  • 18 Inchingolo R, Posa A, Mariappan M. et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: a comprehensive review. World J Gastroenterol 2020; 26 (34) 5060-5073
    CrossrefPubMedGoogle Scholar
  • 19 Fitsiori K, Tsitskari M, Kelekis A, Filippiadis D, Triantafyllou K, Brountzos E. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center. Cardiovasc Intervent Radiol 2014; 37 (03) 691-697
    CrossrefPubMedGoogle Scholar
  • 20 Tripathi D, Macnicholas R, Kothari C. et al. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther 2014; 39 (08) 864-872
    CrossrefPubMedGoogle Scholar
  • 21 Hayek G, Ronot M, Plessier A. et al. Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-Chiari syndrome. Radiology 2017; 283 (01) 280-292
    CrossrefPubMedGoogle Scholar
  • 22 Seijo S, Plessier A, Hoekstra J. et al; European Network for Vascular Disorders of the Liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013; 57 (05) 1962-1968
    CrossrefPubMedGoogle Scholar
  • 23 Sharma AM, Zhu D, Henry Z. Portal vein thrombosis: when to treat and how?. Vasc Med 2016; 21 (01) 61-69
    CrossrefPubMedGoogle Scholar
  • 24 Chamarthy MR, Anderson ME, Pillai AK, Kalva SP. Thrombolysis and transjugular intrahepatic portosystemic shunt creation for acute and subacute portal vein thrombosis. Tech Vasc Interv Radiol 2016; 19 (01) 42-51
    CrossrefPubMedGoogle Scholar
  • 25 Rodrigues SG, Sixt S, Abraldes JG. et al. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis. Aliment Pharmacol Ther 2019; 49 (01) 20-30
    CrossrefPubMedGoogle Scholar
  • 26 Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology 2017; 153 (02) 480-487.e1
    CrossrefPubMedGoogle Scholar
  • 27 Zhan C, Prabhu V, Kang SK. et al. Comparison of non-tumoral portal vein thrombosis management in cirrhotic patients: TIPS versus anticoagulation versus no treatment. J Clin Med 2021; 10 (11) 2316
    CrossrefPubMedGoogle Scholar
  • 28 Luo J, Li M, Zhang Y. et al. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy. Eur Radiol 2018; 28 (09) 3661-3668
    CrossrefPubMedGoogle Scholar
  • 29 Ferrusquía-Acosta J, Hernández-Gea V. TIPS indications and contraindications—pushing the limits: is earlier better?. Curr Hepatol Rep 2019; 18 (01) 87-95
    CrossrefPubMedGoogle Scholar
  • 30 Valentin N, Korrapati P, Constantino J, Young A, Weisberg I. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018; 30 (10) 1187-1193
    CrossrefPubMedGoogle Scholar
  • 31 Keshava SN, Moses V, Sharma A. et al. Technical and medium-term clinical outcomes of transjugular intrahepatic portosystemic shunt with fluoroscopy and additional trans-abdominal ultrasound guidance. Indian J Radiol Imaging 2021; 31 (04) 858-866
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Guevara M, Ginès P, Bandi JC. et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998; 28 (02) 416-422
    CrossrefPubMedGoogle Scholar
  • 33 Amin AA, Alabsawy EI, Jalan R, Davenport A. Epidemiology, pathophysiology, and management of hepatorenal syndrome. Semin Nephrol 2019; 39 (01) 17-30
    CrossrefPubMedGoogle Scholar
  • 34 Arroyo V, Ginès P, Gerbes AL. et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23 (01) 164-176
    CrossrefPubMedGoogle Scholar
  • 35 Angeli P, Ginès P, Wong F. et al; International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 2015; 64 (04) 531-537
    CrossrefPubMedGoogle Scholar
  • 36 Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010; 59 (07) 988-1000
    CrossrefPubMedGoogle Scholar
  • 37 Song T, Rössle M, He F, Liu F, Guo X, Qi X. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: a systematic review and meta-analysis. Dig Liver Dis 2018; 50 (04) 323-330
    CrossrefPubMedGoogle Scholar
  • 38 Charilaou P, Devani K, Petrosyan R, Reddy C, Pyrsopoulos N. Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients. Dig Dis Sci 2020; 65 (11) 3378-3388
    CrossrefPubMedGoogle Scholar
  • 39 Ripoll C, Garcia-Tsao G. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis 2011; 43 (05) 345-351
    CrossrefPubMedGoogle Scholar
  • 40 Mezawa S, Homma H, Ohta H. et al. Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol 2001; 96 (04) 1155-1159
    CrossrefPubMedGoogle Scholar
  • 41 Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118 (05) 905-911
    CrossrefPubMedGoogle Scholar
  • 42 Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol 2003; 4 (02) 109-116
    CrossrefPubMedGoogle Scholar
  • 43 Lipnik AJ, Pandhi MB, Khabbaz RC, Gaba RC. Endovascular treatment for variceal hemorrhage: TIPS, BRTO, and combined approaches. Semin Intervent Radiol 2018; 35 (03) 169-184
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16 (06) 1343-1349
    CrossrefPubMedGoogle Scholar
  • 45 Morrison JD, Mendoza-Elias N, Lipnik AJ. et al. Gastric varices bleed at lower portosystemic pressure gradients than esophageal varices. J Vasc Interv Radiol 2018; 29 (05) 636-641
    CrossrefPubMedGoogle Scholar
  • 46 Kim SK, Lee KA, Sauk S, Korenblat K. Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices. Korean J Radiol 2017; 18 (02) 345-354
    CrossrefPubMedGoogle Scholar
  • 47 Wang ZW, Liu JC, Zhao F. et al. Comparison of the effects of TIPS versus BRTO on bleeding gastric varices: a meta-analysis. Can J Gastroenterol Hepatol. 2020 2020 5143013
    PubMedGoogle Scholar
  • 48 Kochar N, Tripathi D, McAvoy NC, Ireland H, Redhead DN, Hayes PC. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther 2008; 28 (03) 294-303
    CrossrefPubMedGoogle Scholar
  • 49 Norton ID, Andrews JC, Kamath PS. Management of ectopic varices. Hepatology 1998; 28 (04) 1154-1158
    CrossrefPubMedGoogle Scholar
  • 50 Akhter NM, Haskal ZJ. Diagnosis and management of ectopic varices. Gastrointestinal Intervention 2012; 1 (01) 3-10
    CrossrefPubMedGoogle Scholar
  • 51 Oey RC, de Wit K, Moelker A. et al. Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study. Aliment Pharmacol Ther 2018; 48 (09) 975-983
    CrossrefPubMedGoogle Scholar
  • 52 Vangeli M, Patch D, Terreni N. et al. Bleeding ectopic varices–treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation. J Hepatol 2004; 41 (04) 560-566
    CrossrefPubMedGoogle Scholar
  • 53 Sellers CM, Nezami N, Schilsky ML, Kim HS. Transjugular intrahepatic portosystemic shunt as a bridge to liver transplant: current state and future directions. Transplant Rev (Orlando) 2019; 33 (02) 64-71
    CrossrefPubMedGoogle Scholar
  • 54 Valdivieso A, Ventoso A, Gastaca M. et al. Does the transjugular intrahepatic portosystemic influence the outcome of liver transplantation? Transplant Proc. 2012; 44 (06) 1505-1507
    PubMedGoogle Scholar
  • 55 Mumtaz K, Metwally S, Modi RM. et al. Impact of transjugular intrahepatic porto-systemic shunt on post liver transplantation outcomes: study based on the United Network for Organ Sharing database. World J Hepatol 2017; 9 (02) 99-105
    CrossrefPubMedGoogle Scholar
  • 56 Chen B, Wang W, Tam MD, Quintini C, Fung JJ, Li X. Transjugular intrahepatic portosystemic shunt in liver transplant recipients: indications, feasibility, and outcomes. Hepatol Int 2015; 9 (03) 391-398
    CrossrefPubMedGoogle Scholar
  • 57 Lerut JP, Goffette P, Molle G. et al. Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients. Transplantation 1999; 68 (03) 379-384
    CrossrefPubMedGoogle Scholar
  • 58 King A, Masterton G, Gunson B. et al. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation. Liver Transpl 2011; 17 (07) 771-778
    CrossrefPubMedGoogle Scholar
  • 59 Boike JR, Flamm SL. Transjugular intrahepatic portosystemic shunts: advances and new uses in patients with chronic liver disease. Clin Liver Dis 2020; 24 (03) 373-388
    CrossrefPubMedGoogle Scholar
  • 60 Tabchouri N, Barbier L, Menahem B. et al. Original study: transjugular intrahepatic portosystemic shunt as a bridge to abdominal surgery in cirrhotic patients. J Gastrointest Surg 2019; 23 (12) 2383-2390
    CrossrefPubMedGoogle Scholar
  • 61 Vinet E, Perreault P, Bouchard L. et al. Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Can J Gastroenterol 2006; 20 (06) 401-404
    CrossrefPubMedGoogle Scholar
  • 62 Grilo-Bensusan I, Pascasio-Acevedo JM. Hepatopulmonary syndrome: what we know and what we would like to know. World J Gastroenterol 2016; 22 (25) 5728-5741
    CrossrefPubMedGoogle Scholar
  • 63 Wallace MC, James AL, Marshall M, Kontorinis N. Resolution of severe hepato-pulmonary syndrome following transjugular portosystemic shunt procedure. BMJ Case Rep 2012; 2012: bcr0220125811
    CrossrefPubMedGoogle Scholar
  • 64 Tsauo J, Zhao H, Zhang X. et al. Effect of transjugular intrahepatic portosystemic shunt creation on pulmonary gas exchange in patients with hepatopulmonary syndrome: a prospective study. J Vasc Interv Radiol 2019; 30 (02) 170-177
    CrossrefPubMedGoogle Scholar
  • 65 Qi X, Yang M, Fan D, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol 2013; 48 (07) 771-784
    CrossrefPubMedGoogle Scholar
  • 66 Qi X, Guo W, He C. et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int 2014; 34 (08) 1164-1175
    CrossrefPubMedGoogle Scholar
  • 67 Fan X, Liu K, Che Y. et al. Good clinical outcomes in Budd–Chiari syndrome with hepatic vein occlusion. Dig Dis Sci 2016; 61 (10) 3054-3060
    CrossrefPubMedGoogle Scholar
  • 68 Rosenqvist K, Sheikhi R, Eriksson L-G. et al. Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol 2016; 28 (06) 656-660
    CrossrefPubMedGoogle Scholar
  • 69 Chen Y, Ye P, Li Y, Ma S, Zhao J, Zeng Q. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications. Eur Radiol 2015; 25 (12) 3431-3437
    CrossrefPubMedGoogle Scholar
  • 70 Sun X-Y, Wang G-C, Wang J, Huang G-J, Zhang C-Q. Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding. Hepatobiliary Pancreat Dis Int 2021; 20 (02) 128-136
    CrossrefPubMedGoogle Scholar
  • 71 Brensing KA, Textor J, Perz J. et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47 (02) 288-295
    CrossrefPubMedGoogle Scholar
  • 72 Vidal V, Joly L, Perreault P, Bouchard L, Lafortune M, Pomier-Layrargues G. Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients. Cardiovasc Intervent Radiol 2006; 29 (02) 216-219
    CrossrefPubMedGoogle Scholar
  • 73 Amesur NB, Zajko AB, Orons PD, Sammon JK, Casavilla FA. Transjugular intrahepatic portosystemic shunt in patients who have undergone liver transplantation. J Vasc Interv Radiol 1999; 10 (05) 569-573
    CrossrefPubMedGoogle Scholar
  • 74 Tsauo J, Weng N, Ma H, Jiang M, Zhao H, Li X. Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome: a systemic literature review. J Vasc Interv Radiol 2015; 26 (09) 1266-1271
    CrossrefPubMedGoogle Scholar